Contralateral delayed hematoma secondary to anticoagulant treatment-related intracerebral hemorrhage.
The incidence of anticoagulant treatment (AT)-related intracerebral hemorrhage (AT-ICH) is increasing in consequence of the increased incidence of ischemic stroke due to an aging population. AT-ICH is associated with a risk of ongoing bleeding, death, or disability. Cerebral amyloid angiopathy (CAA), a common pathological finding among the elderly that is associated with macro- and microscopic hematoma development, might increase the risk of ICH. We report a rare case of contralateral delayed hematoma in the context of CAA secondary to acute ICH after AT for intracerebral ischemic stroke.
Department of Neurosurgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China. conghai@jlu.edu.cn.
Libo
L
Sun
Yufei
Y
Gao
Chao
C
Fu
Fang
F
Li
Xiaoxuan
X
Fang
Conghai
C
Zhao
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D016657:Cerebral Amyloid Angiopathy / Q000150:complications / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000150:complications; D006406:Hematoma / Q000150:complications*; D006801:Humans; D008297:Male
D000925:Anticoagulants